Research & Markets: Global Bare Metal Stents Market 2011-2015: Abbott Laboratories, Medtronic Inc., Cordis Corp., & Boston Sc...
June 29 2012 - 11:27AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/xg3msr/global_bare_metal)
has announced the addition of the "Global Bare Metal Stents Market
2011-2015" report to their offering.
TechNavio's analysts forecast the Global Bare Metal Stents
market to reach US$1.86 billion by 2015. One of the key factors
contributing to this market growth is the high prevalence of
cardiovascular diseases. The Global Bare Metal Stents market has
also been witnessing the trend of increasing demand for minimally
invasive procedures. However, the presence of alternative coronary
stents could pose a challenge to the growth of this market.
This report has been prepared based on an in-depth analysis of
the market with inputs from industry experts. The report covers the
Americas, and the EMEA and APAC regions; it also covers the Global
Bare Metal Stents market landscape and its growth prospects in the
coming years. The report also includes a discussion of the key
vendors operating in this market.
Key vendors dominating this market space include: Abbott
Laboratories, Medtronic Inc., Cordis Corp., and Boston Scientific
Corp. Other vendors mentioned in the report: Microport Scientific
Corp., Cook Medical, Biosensors International Ltd., B. Braun
Melsungen AG.
Key questions answered in this report:
- What will the market size be in 2015 and at what rate will it
grow?
- What key trends is this market subject to?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the opportunities and threats faced by each of these
key vendors?
- What are the strengths and weaknesses of each of these key
vendors?
- You can request one free hour of analyst time when you
purchase this report. Details provided within the report.
Executive Summary
Commenting on the report, an analyst from TechNavio's Healthcare
team said; The development of new alloys for the manufacture of
coronary stents is expected to lead to an increase in the adoption
of Bare Metal Stents (BMSs) in the treatment of coronary heart
disease (CHD). The usage of new alloys such as cobalt-chromium
(CoCr) and platinum-chromium (PtCr) has led to the design and
manufacture of advanced stents. Traditionally, stainless steel was
used in the production of BMSs. Though flexibility and
deliverability were achieved with the use of stainless steel, there
was a loss of radiopacity and compression strength. These drawbacks
were overcome through the use of CoCr stents, which enabled
manufacturers to design stents with even thinner struts than
before. This technological advancement will help drive the growth
of the Global BMS market.
According to the report, globally, cardiovascular diseases
(CVDs) such as CHD and strokes are on the rise. The increase in the
incidence of CVD is due to a variety of factors, such as obesity,
diabetes, excessive smoking and alcohol consumption, and unhealthy
lifestyles. Further, the rapidly increasing aging population is
increasing the number of people prone to CVD. All these factors
drive the demand in the Global BMS market.
Key Topics Covered:
01. Executive Summary
02. Introduction
03. Market Coverage
04. Market Landscape
05. Geographical Segmentation
06. Key Leading Countries
07. Rate of Incidence and Prevalence
08. Vendor Landscape
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Abbott Laboratories
15.2 Medtronic Inc.
15.3 Cordis Corp.
15.4 Boston Scientific Corp.
16. Other Reports in this Series
For more information visit
http://www.researchandmarkets.com/research/xg3msr/global_bare_metal